Surgical ablation for treating atrial fibrillation during heart surgery
Official title: Surgical Ablation of AF Efficacy Trial
Run by Population Health Research Institute · NCT05434819 · Data updated 2026-11-12
This study is testing if a surgical procedure to treat atrial fibrillation during heart surgery can help patients have better heart health and lower their chances of stroke and heart failure compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Population Health Research Institute Academic / other |
| Locations | 1 site (Hamilton, Ontario) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | September 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT05434819 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have a documented history of paroxysmal or persistent atrial fibrillation and are scheduled for clinically indicated cardiac surgery.
✕Probably not a fit
Patients with dominant atrial flutter, significant left atrial enlargement, or those undergoing specific cardiac procedures unrelated to AF may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The SAFE trial is an international multicenter randomized controlled trial investigating the efficacy of surgical ablation for atrial fibrillation (AF) in patients undergoing cardiac surgery. It aims to determine whether surgical ablation can improve cardiovascular outcomes by maintaining sinus rhythm in patients with paroxysmal or persistent AF. The trial will compare outcomes between patients receiving surgical ablation and those receiving standard care, with a focus on the potential benefits of this intervention in reducing the risk of stroke and heart failure. This landmark trial seeks to provide robust evidence on the impact of surgical AF ablation in the context of cardiac surgery.
Why it matters
Potential benefit: If successful, this trial could significantly improve the management of atrial fibrillation in patients undergoing cardiac surgery, potentially reducing the risk of stroke and heart failure.
How similar studies have gone: Previous studies have shown promising results for catheter-based AF ablation, suggesting that surgical ablation may also yield beneficial outcomes, although this specific approach is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years; * Undergoing a clinically indicated cardiac surgical procedure: CABG, AVR, ascending aorta replacement, or combinations thereof; * Documented history of paroxysmal or persistent AF * Provide informed consent Exclusion Criteria: * Dominant atrial arrhythmia is atrial flutter; * Documented left atrial diameter ≥ 6 cm; * Previous cardiac surgery requiring opening of the pericardium; * Patients undergoing any of the following procedures: 1. Heart transplant 2. Complex congenital heart surgery 3. Sole indication for surgery is ventricular assist device insertion 4. Mitral valve repair or replacement 5. Tricuspid valve repair or replacement * Patient resides in a long-term care facility
Where it's running
-
Hamilton General Hospital
Hamilton, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Richard Whitlock — Population Health Research Institute
- Study coordinator: Richard Whitlock
- Email: Richard.Whitlock@phri.ca
- Phone: 905-521-2100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Village-doctor–led telehealth care to improve outcomes for AF and HF in older adults
A village doctor–led telemedicine program will try to improve heart failure management in rural AF patients aged 65–80 compared with usual care.
-
Village doctor–led telehealth care to prevent heart failure in AF patients
A village doctor–led telehealth program tests whether integrated, guideline-based care can help older adults with atrial fibrillation in rural China stay healthier and avoid heart failure compared with usual care.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
-
Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People
This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.
-
Using BIOMONITOR IV to track heart rhythm and warning signs in people with heart failure
This project will test whether a small implanted monitor called BIOMONITOR IV can track irregular heartbeats and body signals in people with heart failure who do not have ICD/CRT devices to see if it can warn doctors before the heart failure gets worse.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.